Web Extras
Triterpenoids and Chemoprevention: A Dartmouth Collaboration
For 11 years, Dartmouth chemists Gordon Gribble and Tadashi Honda have collaborated with Dr. Michael Sporn, a professor of pharmacology and toxicology at Dartmouth Medical School, to create drugs that prevent and treat cancer. In 1998, Gribble's lab synthesized CDDO, a synthetic triterpenoid. This compound and one of its derivatives are now in Phase I clinical trials for solid tumors and leukemia. To learn more about the Dartmouth triterpenoid project and chemoprevention, read "Compound Interest".
Video
A Q&A with Gordon Gribble
- What are triterpenoids?
- How did you create the synthetic triterpenoids?
- How did you begin working with Dr. Sporn?
- Why has your collaboration with Dr. Sporn been so successful?
- How do triterpenoids relate to cancer prevention?
- Do academic chemists often see their compounds go into trials?
Gordon Gribble Tells the Story of the Triterpenoid Project
See all 
for this issue
If you'd like to offer feedback about this article, we'd welcome getting your comments at DartMed@Dartmouth.edu.
This article may not be reproduced or reposted without permission. To inquire about permission, contact DartMed@Dartmouth.edu.